Skip to article
HSJGlobal

INDONESIA FORMULATED FATS

Margarine Factory Setup in Indonesia: Entity, Industrial Site, and Approvals

Build the entity and approval route around the actual formula, oil and water phases, shared-line risks, packaging, claims, and market channel.

A foreign investor can establish a margarine factory in Indonesia through a PT PMA when KBLI 10412 is open to the proposed ownership and the foreign-investment conditions are met. The legal route must be built around a frozen product portfolio: retail table margarine, bakery margarine, puff-pastry fat, spread, blend, shortening, or another formulated fat may differ in classification, composition, process, packaging, food category, label, halal inputs, and customer evidence.

Do not commit to a site or production line until the team has approved each formula, oil and water phase, emulsification and cooling process, capacity, shared equipment, allergen and dairy status, processing aids, fortification, pack, claims, and buyer. Those details determine whether the deed and OSS scope are accurate, whether the plant layout is hygienically and environmentally viable, and which BPOM, CPPOB, halal, technical-standard, and labelling steps must be complete before sale.

Key takeaways

  • KBLI 2025 code 10412 specifically covers margarine made from edible vegetable oil; shortening and other fats can fall in adjacent coverage, so product names cannot be used interchangeably.
  • A PT PMA generally requires investment exceeding IDR 10 billion, excluding land and buildings, and minimum issued and paid-up capital of IDR 2.5 billion, subject to the exact code and location.
  • Factory suitability depends on hygienic zoning, temperature control, food-contact utilities, oil and ingredient segregation, wastewater and cleaning design, fire safety, and lawful industrial use.
  • CPPOB, BPOM product treatment, nutrition and claims controls, and halal assurance must be assessed formula by formula and pack by pack; an NIB is not product authorization.
  • A release-ready plant can trace every batch from approved oil, water-phase ingredient, processing aid, package, and label through validated process and current certificates.

Define margarine and adjacent fat products before filing

The official KBLI 2025 booklet describes code 10412 as the industry of margarine from edible vegetable oil. Code 10419 covers other crude oils and fats outside coconut and palm groupings and includes shortening in its stated examples. Classification depends on the actual saleable fat product , not a commercial label such as bakery fat.

Portfolio question Why it changes the route Evidence to create
Is the product legally and technically margarine? Controls KBLI 10412, food category, applicable standards, product name and label Composition, water/fat content, emulsion type, process, specification, intended use and proposed name
Is shortening or another fat also made? May require another KBLI, investment allocation, product scope and cleaning controls Separate flow, equipment, specification, packing, customer and line-sharing matrix
Retail or business-to-business? Changes pack, label, registration evidence, traceability and customer documentation Channel, pack size, brand, registration holder, claims and distribution model
Dairy, allergen, flavour or fortified variant? Changes material control, segregation, label, testing, halal and change approval Approved formula, supplier evidence, dosing capability, cleaning validation and claim basis
Private label or toll manufacture? Creates separate brand, formula, dossier, release and recall responsibilities Contractual role matrix, data ownership, change notification, registration and complaint owner

Build a product-family tree that starts with formula and process rather than brand. Variants can share an approval strategy only when the receiving rules permit it and the differences are controlled. Salt level, colour, flavour, vitamin addition, emulsifier, preservative, dairy component, pack, claim, or customer specification may be small to marketing but material to product evidence.

For each output, record whether it is food for direct consumption, an ingredient for another manufacturer, an export-only specification, a sample, rework, off-spec stock, or waste. The status must remain visible in tanks and warehouses. If the plant also refines oil, produces shortening, trades imported fats, or provides contract packing, evaluate those as real activities instead of assuming 10412 absorbs them.

Form the PT PMA and set formula-change governance

Foreign shareholders generally use a PT PMA. Presidential Regulation No. 10 of 2021, as amended by No. 49 of 2021, starts from an open-unless-closed investment model, while conditions can arise from its schedules, sector rules, scale, and location. Check KBLI 10412 and every additional code in the current OSS profile; do not infer an ownership percentage solely from the factory's description.

The usual PMA baseline is planned investment exceeding IDR 10 billion, excluding land and buildings, per five-digit KBLI and project location. PP No. 28 of 2025 includes a manufacturing-line treatment for multiple five-digit product varieties produced on one line. Ministry of Investment/BKPM Regulation No. 5 of 2025 sets minimum issued and paid-up capital at IDR 2.5 billion. Demonstrate how line, product, code, and location figures are allocated.

Prepare current foreign shareholder documents, investment approvals, signatory authority, beneficial-owner data, directors and commissioners, share terms, registered address, business purposes, and appropriate authentication and Indonesian translation. The broader process for Indonesia company registration creates the corporate and OSS account foundation; it does not replace industrial-site or food-product approval.

Board and management authorities should reserve approval for new oils, animal-derived or dairy inputs, processing aids, new claims, higher capacity, another location, toll manufacturing, private label, shared equipment, and imported products. Formula changes cannot be left only to procurement because they can affect KBLI, environment, CPPOB, BPOM, halal, label, customer contracts, and inventory disposition.

Test the margarine portfolio before fixing the KBLI

Share formulas at ingredient-category level, process flow, product names, packs, claims, customers, site, and capacity so entity and product boundaries can be mapped.

Qualify the industrial site and hygienic line design

Map delivery and storage of bulk oils, hardstocks, water-phase ingredients, powders, flavours, additives, packaging, chemicals, and held materials. Follow them through melting or conditioning, oil-phase and water-phase preparation, dosing, emulsification, pasteurization where designed, chilling and working, resting, filling, packing, cold or ambient storage, dispatch, rework, cleaning, laboratory, and waste. Validate the exact process with food technologists and engineers.

Ministry of Industry Regulation No. 37 of 2025 provides current risk-based standards for industry and specified exceptions from the industrial-estate location obligation. The project should normally secure a suitable industrial-estate site unless a documented exception applies. Use a site lease conditional on factory feasibility so the process, tanks, utilities, food production, inspections, environmental controls, and expansion—not merely storage—are permitted.

  • Verify spatial use, owner authority, lease term, industrial-estate status, loading and tank access, pipe routes, setbacks, drainage, flood risk, utility reliability, and emergency access.
  • Separate raw and packaging receipt, allergens and dairy where used, oil and water phases, high-care post-emulsion areas, chemicals, rework, held stock, waste, staff, and dispatch flows.
  • Specify food-contact water, steam where applicable, compressed air, cooling media, refrigeration, power, backup, temperature monitoring, cleaning systems, and hygienic drainage.
  • Assess hot oil, thermal systems, pressure, ammonia or other refrigerant where used, combustible packaging, fire load, confined spaces, chemical compatibility, slips, and machinery guarding.
  • Quantify cleaning wastewater, fat and oil load, product loss, interceptor or pretreatment capacity, sludge, used filters, packaging, laboratory waste, emissions, and lawful outlets.

PP No. 22 of 2021 governs environmental approval and the applicable activity list determines AMDAL, UKL-UPL, or SPPL from scale and location. PP No. 16 of 2021 supplies the PBG and SLF building framework. The applications must describe the same production capacity, shifts, equipment, fuels, refrigeration, water, wastewater, waste, traffic, and storage as the purchased and installed line.

Translate each formula into factory and supplier controls

Create a formula dossier with ingredient identity, function, percentage range, supplier and manufacturer, origin, specification, contaminant and microbiological criteria, allergen and halal status, food-additive permission, storage, shelf life, handling, certificate requirements, and change notification. Trade names are insufficient because one product code may change source or sub-ingredient without an obvious name change.

The oil-phase dossier may cover refined oils, hardstocks, emulsifiers, colours, oil-soluble vitamins, antioxidants, flavours, and processing aids. The water phase may cover water, salt, dairy ingredients, acids, preservatives, stabilizers, flavours, and cultures if relevant. Confirm permissions and use levels for the exact food category under current BPOM rules. Do not copy a foreign formula and assume its additives or claims are permitted in Indonesia.

Process controls should set verified parameters for ingredient release, weighing and dosing, phase temperatures, order of addition, emulsion formation, cooling profile, crystallization and working, residence time, fill weight, metal or foreign-body controls, seal integrity, coding, storage, and release. The approved formula, master batch instruction, and product-registration evidence must remain the same controlled truth.

Control point Failure mode Required evidence
Supplier and material approval Undeclared sub-ingredient, changed oil source, expired halal or unsupported additive Current specification, composition disclosure, certificate, risk review and change agreement
Dosing and formulation Wrong additive, vitamin, water, salt, allergen, or rework amount Access-controlled recipe, calibrated dosing, independent verification, batch record and reconciliation
Emulsion and chilling Instability, water separation, texture failure, or unsafe process deviation Validated parameters, continuous monitoring, alarm and deviation disposition
Packing and label Wrong brand, nutrition panel, claim, allergen, halal mark, code or date Line clearance, approved artwork, barcode/version control, vision or manual check, retained sample
Shared line and cleaning Cross-contact, non-halal carryover, allergen or product residue Campaign plan, validated cleaning, inspection or test, release authorization and traceability

Decide rework rules before production. Identify which product can accept which rework, maximum age and amount, allergen and halal compatibility, traceability, quality effect, and label consequence. A financially attractive rework practice can become an undeclared formula change if it is not included in the validated and approved process.

Margarine formula-to-release map Oil and water phase approvals converge at emulsification and cooling, then pass through pack and label control to final product release. Approved oil phase oils, emulsifiers, vitamins, aids Approved water phase water, salt, dairy, flavours, acids Controlled emulsion process dosing, temperature, chilling, working Pack and label match brand, claim, allergen, code Authorized batch release current dossier + complete record Any material or label change returns to impact review
The two phases are separate supplier and dosing risks, but they converge into one approved product. A change on either side can invalidate the same finished-product evidence.

Map OSS and food approvals without treating the NIB as release authority

PP No. 28 of 2025 is now the governing risk-based business licensing framework and replaced PP No. 5 of 2021. OSS issues the NIB and the risk-dependent business licensing output, potentially including a Standard Certificate or another licence that must be fulfilled or verified. The official current licensing regulation also covers basic requirements and licences supporting business activities. Record the actual status and conditions for 10412 rather than describing every output as a permit.

For food operations, BPOM Regulation No. 27 of 2025 contains current business-activity and product standards for the drug and food subsector. The plant should determine its IP CPPOB path and align the production categories and facility to product registration under the applicable rules. The BPOM 2025 risk-based standards should be applied with the current registration, category, label, additive, contaminant, and claim rules.

Confirm product name, food category, formula, manufacturing process, quality and safety specifications, test methods, packaging, shelf life, nutrition information, allergens, claims, label language, registration holder, manufacturer, brand, and private-label arrangements. A label compliant in another country may use a category, serving, nutrient expression, health claim, ingredient name, or additive description that Indonesia does not accept.

Before claiming a mandatory or voluntary SNI position, search the current technical regulations by product and tariff code. No blanket statement that every margarine product is under the same mandatory-SNI scheme should be made from KBLI alone. If a customer requests an SNI or another certification voluntarily, keep that commercial certification distinct from statutory market authorization.

PP No. 42 of 2024 governs halal assurance. A medium or large food manufacturer is already within the mandatory phase. Establish an SJPH system covering policy and responsibility, materials, product names, facilities, cleaning, storage, transport, subcontracting, traceability, nonconforming product, internal audit, management review, and change. Verify compound ingredients to sub-ingredient level rather than relying only on a distributor declaration.

Align the formulation with the factory evidence

Connect tanks, dosing, emulsification, cooling, packing, cleaning, utilities, allergens, waste, and laboratory controls to the premises and product applications.

Prepare an approval evidence matrix with completion criteria

Assign each fact to a source record, owner, reviewer, filing, validity date, and change trigger. This prevents the deed, OSS, environmental report, layout, CPPOB file, product dossier, halal system, and customer specification from evolving independently. The matrix should contain the approved value and also link to evidence, not copy uncontrolled text across files.

Workstream Core evidence Completion criterion
Entity and OSS Shareholder documents, deed, AHU, beneficial ownership, NPWP, NIB, KBLI rationale, risk outputs, investment plan Names, authority, code, location, capital, and licence effectiveness reconcile
Site and engineering Land/lease, estate and spatial evidence, basis of design, environmental approval, PBG/SLF, utility and safety records Legal rights and permitted design cover the installed line and maximum operating case
Facility and quality Layout, equipment, utilities, zoning, sanitation, pest, maintenance, calibration, laboratory, traceability, recall and CPPOB The facility operates under approved procedures and produces repeatable compliant trial batches
Formula and product Specifications, supplier approvals, composition, additive assessment, process, tests, pack, shelf life, label, BPOM and change files Every marketed variant maps to current formula, site, pack, label and authorization
Halal and commercial SJPH, material evidence, cleaning, storage, transport, certificate, contracts, private-label roles and complaint process Released product and customer commitments remain inside certified and contracted scope

Foreign corporate documents may need apostille or legalization, certified copies, current registry dates, and sworn Indonesian translation depending on the receiving party. Supplier documents may need manufacturer-level composition and halal evidence protected by confidentiality. Use controlled disclosure or regulator-facing arrangements instead of accepting a commercial refusal to reveal critical composition.

Define completion conservatively. An application receipt is not an effective licence; a certificate for another site or product is not transferable by assumption; an equipment factory-acceptance test is not site qualification; and a compliant laboratory sample is not proof that every production batch is controlled. Each workstream closes only when its evidence is valid for this company, site, line, product, and date.

Stage validation and commercial release around stable facts

Use a dependency schedule instead of promising one number of weeks. Shareholder authentication, incorporation, OSS, site diligence, environmental and building review, design and construction, utility commissioning, supplier qualification, CPPOB readiness, product registration, label correction, shelf-life work, halal audit, and trial production have different owners and prerequisites. Authority clocks generally exclude incomplete applicant preparation and later correction.

  1. Freeze the product-family tree, formulas, proposed names, process, packs, claims, customers, KBLI, ownership, investment, location, and decision authorities.
  2. Complete PT PMA, tax and OSS foundations while the site and facility basis of design is tested against the controlled portfolio.
  3. Secure site rights and applicable spatial, estate, environmental, building, utility, industrial, safety, water, waste, and supporting approvals before irreversible works.
  4. Install and qualify utilities, storage, dosing, process, chilling, packing, cleaning, laboratory, traceability, and environmental controls against approved drawings.
  5. Demonstrate repeatable trial batches; finalize specifications, shelf life, packs and labels; complete applicable CPPOB, BPOM, halal and technical-standard steps.
  6. Authorize commercial release, transfer all conditions to the operating calendar, and place every future formula, supplier, process, site or label change under review.

Parallelization should follow information stability. Company preparation can overlap with conditional site diligence, and label design can begin using a controlled draft. Product submission should not precede formula and process freeze, and site construction should not outrun environmental or building assumptions. If the commercial portfolio changes, re-baseline only affected tasks rather than concealing the change in later documentation.

The first-sale gate should require effective licences, accepted site use, operational utilities and treatment, completed facility qualification, released suppliers and materials, approved formula and master instruction, acceptable representative results, correct packaging and label, halal evidence, traceability and recall capability, and named continuing-compliance owners.

Manage supplier, shared-line, and label changes after startup

A change can enter through procurement, research, production, marketing, maintenance, a customer, or a regulator. Route every new oil source, emulsifier, flavour, vitamin premix, preservative, dairy ingredient, processing aid, lubricant, cleaning chemical, packaging, claim, artwork, supplier site, process setting, line, capacity, or contract manufacturer through a single change-control owner.

The assessment should check safety and quality, BPOM category and registration, additive permissions, nutrition and claims, allergens, halal, CPPOB, environmental and waste effects, equipment and cleaning, validation, inventory transition, customer notification, contracts, and filing timing. Release the change only after required approval, updated documents, training, and verified implementation.

Many margarine customers operate bakery, biscuit, confectionery, or other downstream factories and depend on stable ingredient specifications. The linked analysis of biscuit-factory ingredient and label controls shows why a change to fat functionality, allergen, halal evidence, or declaration can create a separate customer approval issue even when the margarine remains saleable.

Deviation Containment Evidence for release or disposition
Wrong formula or dosing Stop line; quarantine affected and potentially commingled batches Batch reconciliation, investigation, risk assessment, testing, lawful disposition, corrected control and approval
Unapproved supplier change Block material and dependent product Full source/composition review, quality and halal acceptance, regulatory impact decision, updated supplier file
Incorrect label or pack Block dispatch and identify distributed lots Artwork/version investigation, relabel or recall decision, regulator/customer action where required, line-clearance correction
Cleaning or cross-contact failure Hold subsequent production and isolate equipment Validated re-cleaning, inspection/test, affected-lot assessment, root cause and preventive action
Installed capacity differs from permits Do not operate the unassessed expansion Integrated OSS, environment, building, utility, food-system and product review with completed changes

Keep original records and an auditable disposition. Relabelling, rework, downgrading to business-to-business use, export, destruction, or return all need a lawful basis and traceability. Closing a deviation without controlling physical stock can produce an unauthorized sale even if the procedure has been corrected.

Approve or pause the margarine project against the formula-to-release chain

Proceed when the product-family tree supports KBLI 10412 and any adjacent code; PT PMA ownership, capital, and investment are defensible; the industrial site and design fit the maximum process; and every formula has a controlled supplier, process, pack, label, CPPOB, BPOM, halal, and technical-standard route. The same identifiers and capacities should appear across corporate, premises, product, and operational records.

Pause if margarine and shortening are used interchangeably, compound ingredients lack composition evidence, a shared line has no cleaning strategy, the landlord cannot support food production and utilities, or claims and labels are being finalized after filing. Escalate animal-derived or dairy materials, hydrogenation or other special processing, novel fats, private-label control conflicts, multiple sites, and uncertain product categorization before commitment.

Decide whether the margarine project is filing-ready

HSJGlobal can coordinate the company and OSS route after the portfolio, ownership, investment, site, formula governance, and specialist approval owners are confirmed.

Frequently asked questions

What KBLI applies to margarine manufacturing in Indonesia?

KBLI 2025 code 10412 is the starting point for margarine made from edible vegetable oil. Shortening and other oils or fats can fall in adjacent coverage, so confirm each formula, process, and saleable output.

Can a foreign investor set up a margarine factory?

Potentially through a PT PMA, subject to the exact KBLI's current foreign-ownership position, investment and capital rules, location, and sector conditions. Ownership permission does not replace factory or product approvals.

Does one BPOM registration cover every flavour and pack?

Do not assume so. Formula, food category, brand, pack, net content, label, claim, manufacturer, and registration rules determine whether a variant can share a route or needs separate action.

Is halal certification relevant when all oils are vegetable-based?

Yes. Halal assessment extends beyond the headline oil to emulsifiers, flavours, vitamins, processing aids, compound ingredients, shared equipment, cleaning, storage, transport, packaging, and traceability.

Can a warehouse be converted into a margarine plant?

Only if industrial and spatial use, lease authority, environmental and building routes, utilities, drainage, food layout, refrigeration, fire and safety controls, and regulator access are proven for the actual process.

What is the final commercial-release evidence?

Effective licences and approvals, qualified premises and equipment, approved materials and formula, validated process and cleaning, acceptable batch results, correct registered label and pack, halal support, complete traceability, and an authorized release record.

On this page
Chat with an Expert